INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Ekso Bionics Holdings, Inc.

[ACCESSWIRE]

LOS ANGELES, CA / ACCESSWIRE / February 7, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Ekso Bionics Holdings, Inc. ("Ekso" or the "Company") (NASDAQ: EKSO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's shares between March 15, 2017 through December 27, 2017, inclusive (the "Class Period"), are encouraged to contact the firm before March 5, 2018, the lead plaintiff motion deadline.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the complaint, the Company failed to disclose that: (1) there was a material weakness in Ekso's internal control over financial reporting and Ekso's disclosure controls and procedures were not effective; and (2) as a result, Defendants' public statements were materially false and misleading at all relevant times.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.